SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-20-000294
Filing Date
2020-07-02
Accepted
2020-07-02 16:16:07
Documents
1
Period of Report
2020-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 06-23-2020 form_3.html 3  
1 FORM 3 FOR 06-23-2020 form_3.xml 3 7422
  Complete submission text file 0001161697-20-000294.txt   9055
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address
Del Carmen Jeffrey (Reporting) CIK: 0001816477 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 201009506